The Pros, Cons, and Considerations of Taking Ozempic and Other Drugs for Weight Loss

The Pros, Cons, and Considerations of Taking Ozempic or Other Drugs for Weight Loss

The Pros, Cons, and Considerations of Taking Ozempic or Other Drugs for Weight Loss
Jason Bergman/AP Photo

Many people who have struggled to lose weight their entire lives have found the new generation of GLP-1 weight loss drugs exceptionally helpful. But if you’ve been considering asking your doctor for a prescription, there are some things you should know first. Here’s what experts say about research on the effectiveness of semaglutide (Ozempic, Wegovy) and a similar GIP/GLP-1 medication, tirzepatide (Mounjaro, Zepbound) and when to consider them for weight loss.

Who’s a Good Candidate for Weight Loss Medications?

Leading endocrinologist Caroline Messer, MD, offers her advice on these buzzy weight loss medications.
Who’s a Good Candidate for Weight Loss Medications?

How Ozempic and Similar Drugs Work

Ozempic and similar drugs have several functions that make them helpful for managing diabetes and weight loss.

Decreasing Hunger and Increasing Satiety

Many weight loss drugs of the past had questionable results, but semaglutide and tirzepatide may be game changers for weight control. “These newer medications work on a different physiologic pathway from some of the other medications,” says Kimberly Gudzune, MD, MPH, chief medical officer of the American Board of Obesity Medicine, who is based in Baltimore. Whereas some anti-obesity drugs decrease the amount of dietary fat that the body absorbs, semaglutide affects hormones involved in hunger and satiety.

One global survey cited the inability to control hunger as a key barrier to weight loss for adolescents with obesity.

Lowering Blood Sugar and Slowing Digestion

Semaglutide and tirzepatide mimic the natural hormone glucagon-like peptide 1 (GLP-1), which helps regulate hunger and feelings of fullness. GLP-1 lowers blood sugar levels by helping the pancreas produce more insulin, thus preventing the liver from releasing too much sugar and slowing the rate at which food travels through the digestive system.

Quieting Food Noise

Dr. Gudzune has patients taking semaglutide and tirzepatide who have reported feeling full on smaller portions, and many describe a reduction in “food noise” (ever-present thoughts about eating and food).

Lowering Body Weight

According to the American Diabetes Association, actions like lowering blood sugar and slowing digestion can help treat diabetes, a condition in which an inability to make or properly use insulin severely reduces blood sugar control.

 These drugs have other metabolic benefits, including weight loss.

Evidence also shows that medications like semaglutide and tirzepatide are much more efficacious, meaning that they lead to a higher total body weight loss more quickly than other medications that clinicians have historically prescribed to treat obesity, says Rekha Kumar, MD, head of medical affairs at the medically assisted weight loss program Found and an endocrinologist in New York City.

Several studies have shown that semaglutide can have a profound impact on body weight. One large study showed that more than 1 in 4 people who took the drug for a year lost 20 percent or more of their weight.

 Similar research found that people who took tirzepatide lost nearly 20 percent of their weight.

Semaglutide and Similar Medications for Weight Loss

While semaglutide is quite effective for weight loss, not everyone is a suitable candidate for it. Doctors primarily prescribe Ozempic as a diabetes treatment. But the FDA has approved the same drug as an overweight and obesity treatment under the name Wegovy.

A similar drug (tirzepatide) is sold as Mounjaro for diabetes and also won FDA approval in November 2023 to treat obesity under the name Zepbound. A clinical trial showed that tirzepatide helped people lose, on average, almost one-quarter of their body weight when they used it continuously and alongside intensive lifestyle changes.

Who Should Use Ozempic or Similar Medications for Weight Loss?

Ozempic can be used off-label for weight loss in the absence of a health condition, but that doesn’t mean it’s a good idea. For starters, these drugs may be useful for weight loss only if your body mass index (BMI) is higher than 30.

In addition, if you use semaglutide or tirzepatide, that doesn’t mean you can forget about following a healthy lifestyle. “People should always pursue a healthy diet for their overall cardiometabolic health and for adequate nutritional status,” says Dr. Kumar. “No medication or supplement can counteract the effects of a bad diet.” Regular exercise, good hydration, and quality sleep are other habits crucial for overall health and better weight loss results.

As for who is a good candidate for these drugs, there are no official criteria. “Right now we use BMI combined with other medical conditions to determine eligibility for a medication,” says Gudzune. She says that anyone with a BMI of 30 or greater or anyone who has a BMI of at least 27 and also has another weight-associated medical condition (such as high blood pressure) is a potential candidate for medication. But it’s important for anyone considering medicated weight loss to discuss the options with a knowledgeable healthcare provider.

The Realities of Weight Loss

If you’ve attempted weight loss in the past only to find pounds creeping back onto your frame, you know that it’s rarely easy.

“Obesity is a complex condition — so many factors contribute to its occurrence (and reoccurrence) over time, and these factors are not the same for all people,” says Gudzune.

It can be frustrating and discouraging when someone repeatedly fails at weight loss or loses only to regain. These new classes of drugs have been giving those people hope. “For people who have not had success with lifestyle alone or have been previously unsuccessful with other medications, these medications offer a new option that may support their health goals,” Gudzune says.

But some celebrities and people who may not really need them are using the weight loss medications somewhat inappropriately. While these folks may talk a lot about their success with Ozempic for weight loss, it’s important to remember that no one strategy is a magic bullet for shedding pounds.

Side Effects and Other Factors to Consider

If you do decide to give Ozempic or another similar medication a try, be aware that while they may seem like miracle drugs, they are not without downsides. Here are some factors to consider.

Cost

Depending on your insurance coverage, semaglutide can be quite expensive. According to Novo Nordisk, the manufacturer of Ozempic, the list price for a 0.25, 0.5, 1, or 2 milligram (mg) injection pen is $997.58.

 Fortunately, some insurance plans may bring this cost down. Higher doses of Zepbound for weight loss cost more than $1,000 before insurance.

Delivery Method

Afraid of needles? Most of these medications are delivered via injection, but Wegovy and Rybelsus (a semaglutide that is primarily prescribed to treat diabetes) are FDA-approved oral GLP-1s.

Treatment Length

Once you start taking weight loss medications, you’ll likely need to stay on them to maintain results. “Patients considering any anti-obesity medication as a treatment option should be prepared to take these medications long-term — [that’s how] we see the best outcomes in the scenario for achieving and, most importantly, sustaining all the health benefits achieved,” says Gudzune.

Side Effects

You may also experience some unpleasant side effects while on the drugs.

 These may include the following:

Your Other Health Conditions

Tell your doctor if you’ve had problems with your kidneys or pancreas, if you have a history of diabetic retinopathy, or if you are pregnant, breastfeeding, or plan to be. These conditions may affect whether you can use this drug.

Some evidence suggests that people with certain other medical conditions should avoid these drugs, too. “People who have a history or family history of a rare thyroid cancer (medullary thyroid carcinoma) should not use this medication,” says Gudzune. Similarly, anyone with a history of pancreatitis should discuss the safety of these medications with a healthcare provider.

Finally, individuals with a history of disordered eating should discuss the drugs with their doctor and therapist before starting.

Unknowns

As prescription drugs go, semaglutide and tirzepatide are relatively new, so there’s a lot we still don’t know about them. Studies have not documented the effects of decades-long use of semaglutide and tirzepatide.



Kumar points out that there’s minimal research on their effects on people with normal weight. “While it is true that taking [these drugs] may benefit those with overweight or obesity, testing hasn’t assessed the effects of Ozempic in those without obesity — meaning people who want to lose those extra ‘vanity pounds.’ So there’s no way to know what sort of weight loss or side effects can happen with inappropriate use.”

Remember, too, that as effective as these medications may be, they can’t solve emotional issues related to eating and weight. Depending on your relationship to food, it may be best to approach weight loss from a more comprehensive perspective that addresses the physical and the emotional.

The Takeaway

  • Many celebrities are using Ozempic, a diabetes drug, as a weight loss aid, but unlike Wegovy and Zepbound, it’s not approved by the FDA for that purpose.
  • Although these medications have shown promising results, they come with risks and should be taken under a healthcare provider’s supervision.
  • Before considering such drugs, make sure you are following a healthy diet and regular exercise program, and consult with your doctor to explore all options.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Weight Loss Medications. Cleveland Clinic. September 12, 2025.
  2. López Siguero JP et al. Attitudes, Behaviors, and Barriers among Adolescents Living with Obesity, Caregivers, and Healthcare Professionals in Spain: ACTION Teens Survey Study. Nutrients. June 30, 2023.
  3. Mahapatra MK et al. Semaglutide, a Glucagon Like Peptide-1 Receptor Agonist With Cardiovascular Benefits for Management of Type 2 Diabetes. Reviews in Endocrine & Metabolic Disorders. January 7, 2022.
  4. Ozempic (semaglutide). American Diabetes Association.
  5. Ruseva A et al. Semaglutide 2.4 MG Long-Term Clinical Outcomes in Patients With Obesity or Overweight: A Real-World Retrospective Cohort Study in the United States (Scope 12 Months). Postgraduate Medicine. March 27, 2025.
  6. Lui L et al. Efficacy and Safety of Tirzepatide Versus Placebo in Overweight or Obese Adults Without Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. International Journal of Clinical Pharmacy. July 22, 2024.
  7. Aronne LJ et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA. December 11, 2023.
  8. Does Ozempic Work for Weight Loss? Cleveland Clinic. December 18, 2025.
  9. Find out the cost for Ozempic. NovoCare.
  10. How Much Should I Expect To Pay for Zepbound (Tirzepatide)? Lilly.
  11. GLP-1 Agonists. Cleveland Clinic. July 3, 2023.
  12. Novo Nordisk A/S: Wegovy Pill Approved in the US as First Oral Glp-1 for Weight Management. Novo Nordisk. December 22, 2025.
  13. Semaglutide (Subcutaneous Route). Mayo Clinic. January 1, 2026.
  14. Important Safety Information Ozempic (Semaglutide) injection 0.5 mg or 1 mg. Ozempic.
Sean-Hashmi-bio

Sean Hashmi, MD

Medical Reviewer

Sean Hashmi, MD, is an experienced nephrologist and obesity medicine specialist based in Southern California. As the regional director for clinical nutrition and weight management at a prominent healthcare organization in Southern California, Dr. Hashmi oversees the development and implementation of cutting-edge nutritional programs and weight management strategies. With his innovative approach and unwavering commitment to providing evidence-based solutions, he is a highly sought-after speaker and a leader in his field.

Hashmi founded the nonprofit organization SelfPrinciple.org to provide accessible and accurate health, nutrition, and wellness information to the public. Through this platform, he shares the latest research findings, empowering individuals to make informed decisions about their well-being. Self Principle also supports children's education by providing scholarships, books, and supplies, so that students have the resources necessary to succeed academically and build a brighter future.

Sarah-Garone-bio

Sarah Garone

Author
Sarah Garone is a licensed nutritionist, registered nutrition and dietetics technician, freelance health and wellness writer, and food blogger in Mesa, Arizona. She has written for The Washington Post, Healthline, Greatist, Verywell, and Eat This, Not That, among other outlets. She is a member of the Academy of Nutrition and Dietetics.